Jochen Springer
9Patents
1h-index
4Co-inventors
40Inventor score
Filing activity: Apr 29, 2010 → Feb 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10016397B2 | Selective AT2 receptor agonists for use in treatment of cachexia | Chemistry; Metallurgy | 2 | Active |
| US10398658B2 | Oxprenolol compositions for treating cancer | Human Necessities | 1 | Active |
| US10828270B2 | Oxprenolol compositions for treating cancer | Human Necessities | 1 | Active |
| US8835485B2 | Prevention and treatment of sarcopenia | Human Necessities | 1 | Active |
| US12303474B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US11433036B2 | Oxprenolol compositions for treating cancer | Human Necessities | 0 | Active |
| US11007158B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US11938102B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US10449166B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.